“At this point, we are not concerned that the patient has Ebola.” – Griffin Hospital spokesm

DERBY – A man who recently traveled to Liberia sparked an emergency Ebola response plan after he was taken to Griffin Hospital in an ambulance Saturday night, but the patient has since been transferred to Yale-New Haven Hospital and medical personnel do not believe that he actually has the deadly virus.

"We determined that he was no longer considered an elevated risk," hospital spokesman Ken Roberts said Monday.

Roberts said that hospital staff determined Sunday afternoon to transfer the patient to Yale-New Haven after determining that the patient was not an Ebola threat.

"The patient they transferred here was not transferred for Ebola," Yale-New Haven spokesman Mark D' Antonio said Monday.

The man had a condition "not symptomatically related to Ebola," and the action was taken because the man had been to Liberia within the past 21 days, Roberts said Sunday.

The federal Centers for Disease Control and Prevention and the state Department of Public Health were notified, Roberts said.

Protein Sciences, a biomedical research company in Meriden is working on an Ebola vaccine. Work on the vaccine is mostly self-funded at this point, the company said. If the vaccine proves itself in tests, the National Institutes of Health would fund further development and production.

Those taking care of the patient followed the hospital's Ebola isolation procedures, Roberts said, and the patient and the medical staff caring for him were kept isolated from other patients.